Licensed Drug Wholesaler & Retailer · GSTIN 07HAMPS6624H2Z3 Mon – Sat: 9:30 AM – 8:00 PM

Generic vs Branded Speciality Medicines in India: What Patients Should Know

Are generic cancer, HIV and hepatitis medicines as good as branded ones? Understand bioequivalence, biosimilars, pricing and how to discuss options with your doctor.

Generic vs Branded Speciality Medicines in India: What Patients Should Know

India is often called the “pharmacy of the world” because it manufactures high-quality generic medicines at a fraction of the cost of the original brands. For patients on long-term speciality therapy, understanding generics can make treatment far more affordable.

What is a generic medicine?

A generic medicine contains the same active ingredient, in the same strength and dosage form, as the original (innovator) product. In India, generics are approved by the Central Drugs Standard Control Organisation (CDSCO) and must meet the same quality standards as any other medicine sold in the country.

Bioequivalence: the key concept

For most oral medicines such as tablets and capsules, a generic must show bioequivalence — meaning it delivers the same amount of active ingredient into the bloodstream at the same rate as the reference product. That is why many oncology, HIV and hepatitis C treatments in India are widely prescribed as generics.

Biosimilars are different

Biological medicines such as trastuzumab, bevacizumab or erythropoietin are made in living cells and cannot be copied exactly. Their follow-on versions are called biosimilars. They go through additional comparative studies to show they are highly similar in quality, safety and efficacy. Switching between a biologic and a biosimilar should always be a decision made with your doctor.

Why is there such a big price difference?

Innovator companies recover the cost of research, clinical trials and patents through their pricing. Generic manufacturers do not carry those costs, so they can offer the same molecule for much less. Competition between several generic brands drives prices down further.

Innovator brand Generic / biosimilar
Active ingredient Original molecule Same molecule (biosimilar: highly similar)
Regulatory approval CDSCO CDSCO
Cost Higher Usually much lower
Availability Sometimes limited Often multiple brands

How to discuss it with your doctor

  • Ask whether a generic or biosimilar of your prescribed medicine is suitable for your condition.
  • Ask your doctor to write the generic name (and brand, if they prefer one) on the prescription.
  • Once you are stable on a particular brand, avoid frequent switching unless advised.
Only your treating doctor can decide whether substitution is appropriate. A pharmacy can tell you which brands are available and their prices.

How we help you choose

K26 Pharmaceuticals can share quotations for multiple approved brands of the same molecule so that you and your doctor can make an informed choice. Browse medicines or talk to our team.

Medical disclaimer: This article is for general information only and does not replace advice from your treating doctor. Never start, stop or change a medicine without consulting a registered medical practitioner.

Leave a Reply

Your email address will not be published. Required fields are marked *